Association between Vitamin D Serum Levels and Immune Response to the BNT162b2 Vaccine for SARS-CoV-2
Biomedicines. 2022 Aug 17;10(8):1993.doi: 10.3390/biomedicines10081993.
Paola Zelini 1 , Piera d'Angelo 2 , Emanuele Cereda 3 , Catherine Klersy 4 , Peressini Sabrina 5 , Riccardo Albertini 5 , Giuseppina Grugnetti 6 , Anna Maria Grugnetti 6 , Carlo Marena 7 , Sara Cutti 7 , Daniele Lilleri 1 , Irene Cassaniti 1 8 , Baldanti Fausto 1 8 , Riccardo Caccialanza 3
The use of micronutrients such as vitamin D could improve the response to viral vaccines, particularly in immunosuppressed and immunosenescent subjects. Here, we analysed the association between serum 25-hydroxyvitamin D (25OHD) levels and the immune response elicited by the BNT162b2 vaccine in a cohort of 101 healthcare workers naïve for SARS-CoV-2 infection. We observed no significant differences in anti-spike (S) IgG and T-cell responses according to the 25OHD status at baseline. However, significant correlations between the 25OHD concentration at baseline and (i) the anti-S response (p < 0.020) and (ii) the neutralizing antibody (NT) titre (p = 0.040) at six months after the second dose were detected. We concluded that adequate levels of vitamin D may improve the immune response to mRNA vaccines such as BNT162b2, and that further larger studies are warranted in order to confirm these preliminary observations.
Download the PDF from VitaminDWiki
See related studies in VitaminDWiki
- Micronutrients such as vitamin D should improve vaccine effectiveness (and decrease side effects) – April 2022
- Vitamin D might augment COVID-19 vaccines – 6 papers as of Dec 2021
- Pfizer vaccine produced 30 percent more antibodies if more vitamin D – July 2022
- COVID vaccination makes 6X more antibodies in those having good levels of both vitamin D and Iron – June 2021